Role of targeted agents in metastatic colorectal cancer. - Wikidata - awgldk - TriplyDB

Role of targeted agents in metastatic colorectal cancer.

Role of targeted agents in metastatic colorectal cancer.

http://www.wikidata.org/entity/Q38104294

about

Oncological emergencies associated with gastrointestinal tumors A Disintegrin and Metalloproteinase Domain 17 Regulates Colorectal Cancer Stem Cells and Chemosensitivity Via Notch1 Signaling.IgE-based Immunotherapy of Cancer -A Comparative Oncology Approach Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer Nimotuzumab in combination with radiotherapy in high grade glioma patients: a single institution experience.Regorafenib as a single-agent in the treatment of patients with gastrointestinal tumors: an overview for pharmacists.Prospective noninterventional study on the use of panitumumab monotherapy in patients with recurrent or progressive colorectal cancer: the VECTIS study.Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors.LGALS3 and AXIN1 gene variants playing role in the Wnt/ β-catenin signaling pathway are associated with mucinous component and tumor size in colorectal cancer Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis.Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept.Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents.KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors.PHD1 regulates p53-mediated colorectal cancer chemoresistance.UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.Combining trail with PI3 kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling.Toward a common therapeutic framework in castration-resistant prostate cancer: a model for urologic oncology and medical oncology interaction.Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.Colorectal Cancer Screening: A Comprehensive Review to Recent Non-Invasive Methods.Molecular genetics of colorectal cancer.Antiangiogenesis therapy in second line metastatic colorectal cancer: similar but different.Biweekly cetuximab plus FOLFIRI/irinotecan as first/second-line chemotherapy for patients with KRAS wild-type metastatic colorectal cancer: a retrospective analysis in Southwest Chinese population.Liposomal 64Cu-PET Imaging of Anti-VEGF Drug Effects on Liposomal Delivery to Colon Cancer Xenografts.Macrophage conditioned medium promotes colorectal cancer stem cell phenotype via the hedgehog signaling pathway.Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy: A Single-Institution Experience.Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells.Acriflavine enhances the antitumor activity of the chemotherapeutic drug 5-fluorouracil in colorectal cancer cells.

P2860

Q26783725-914A0857-43BF-43C3-8F78-0717F1B1ED28 Q27301073-25508D81-137E-4BAA-9E4C-6E94BE48D300 Q28655505-9F83811C-B348-4AC1-899A-B83E49388423 Q33631430-0FBF2117-C10A-45B9-9C48-586413CEB30A Q33631435-78BCB74F-2900-4BD9-A374-4B6C7B91B7DC Q35689747-98D2F73F-5CD7-4F35-A333-655F1B06D5F3 Q36232353-95C8F024-3190-47D8-96C4-08DA9234DB88 Q36544553-55C84076-05A9-4018-B985-7E69CF19A0BD Q36857748-C25708FD-9680-4AC1-99B7-BBE1FF4CDA34 Q37269328-DF7D3CF0-1EF4-4661-8E0A-5C91450953EA Q37447620-FC089EA4-1134-4E85-A5C3-8BF16E8C0368 Q38241190-1D9CDE28-A39D-4BE8-88D7-FE5E65A08976 Q38594420-09AC3FD6-DE84-41B5-B216-953C90F95701 Q38765961-EDE64E35-00B5-4872-88CE-B2DB7E3CE743 Q38842390-D9B79ADC-0326-499E-893C-4D70B3B3AB57 Q38881708-9C40D525-A567-46F0-AB85-6412C1E49C76 Q39126075-C32BDB39-2ABA-4E7F-8276-2CBB403CA379 Q41099750-E309BEB7-D3EA-44DF-8D86-CE1FE3497EB5 Q41985832-9C986C9E-D934-47D6-89AF-BBE25643B26C Q42229907-14C649DF-0A3E-47CB-AFB4-DCF2BF913428 Q42406512-6EA24854-B990-43BB-95CD-22AE8E723C9F Q43580379-5C4EA1C1-A4CE-48C0-BC7D-7EFAF6CF683C Q43885266-3D081EB0-383D-442B-B567-DF360671A79D Q47118009-ACFF2965-D5B4-4264-862F-3034BBF49D83 Q47224069-E4EAEAD6-C19C-46EF-8C76-89C712AD87EA Q47301004-98BF385B-E473-4E07-9B02-B3B8EBB12662 Q48287357-B9AF070F-83E6-42E6-9EA2-58AD366B6361 Q55365354-D0335F45-A79D-4260-AC33-1DF8BCE04F74

P2860

Role of targeted agents in metastatic colorectal cancer.

http://www.wikidata.org/entity/Q38104294

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Role of targeted agents in metastatic colorectal cancer.

@en

type

label

Role of targeted agents in metastatic colorectal cancer.

@en

prefLabel

Role of targeted agents in metastatic colorectal cancer.

@en

P1433

Q38104294-E19D8121-BC9E-44C2-986A-DE4F9191A285

P1476

Q38104294-68A7727A-2123-4C2B-BF44-8B17723CFD38

P2093

Q38104294-A9CB1AD2-8B89-4BDF-AF75-E5E4EF50CBF9

Q38104294-B01AE869-367E-4E7C-8C8A-5DE75707DF71

P2860

Q38104294-022BAB2C-A825-4A11-8B78-3520CDBB8B95

Q38104294-03A0CF2B-4890-4481-9505-ED402BD971D5

Q38104294-05D77386-85FA-4985-894D-ED271A317EC9

Q38104294-0824AEAC-C82C-41F7-B89B-A4D28E970C76

Q38104294-0D1B1287-3EE0-4A4C-8C09-94D816E40095

Q38104294-1082D408-F3F6-4D7D-81CE-987376B9890F

Q38104294-1256E79D-07A9-483B-B7EA-8495CABB3EA2

Q38104294-158B20E6-D51E-43F2-A006-847F5B06B5C6

Q38104294-1674F8A3-BE24-4449-8529-ECA2D3A64D3A

Q38104294-173E134E-9AF9-45D3-9F35-607F11E1EF2F

P2888

Q38104294-2B3BEDDA-3F9C-4F02-BE2C-971B1655135E

P304

Q38104294-ABBF3564-E7A1-4456-9ADC-2BF8ADB0BB16

P31

Q38104294-876345D1-F4D6-4AC0-AB0E-ABDFE180D5E0

P356

Q38104294-56A81C9A-A5EC-4D53-B0E4-4AD1DAD5AFD0

P433

Q38104294-72CEFDC6-950D-4271-BF2A-C8CAFA625A5E

P478

Q38104294-3323A6D9-D190-433F-9B1A-63B147158442

P50

Q38104294-B6AEC4AE-5CFC-451F-83B1-F92870A4C154

P577

Q38104294-B44B8983-7E6F-42A2-8367-E51841B2049E

P5875

Q38104294-DA8C57DC-3CEA-444E-83B7-D73DA85B7305

P6179

Q38104294-D333C619-CB12-4595-8DBE-C59BDB454D6A

P698

Q38104294-74EBF81D-59AE-4A53-8574-B0FC065E9FC4

P921

Q38104294-B14AF5DE-EAAC-46F2-8061-F2471EF024A9

P356

S11523-013-0281-X

P1433

Targeted oncology

P1476

Role of targeted agents in metastatic colorectal cancer

@en

P2093

Eric Van Cutsem

http://www.w3.org/2001/XMLSchema#string

Loredana Vecchione

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

Cetuximab for the treatment of colorectal cancer.

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study.

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

P2888

s11523-013-0281-x

P304

83-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11523-013-0281-X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236639261

http://www.w3.org/2001/XMLSchema#string

P6179

1001385357

http://www.w3.org/2001/XMLSchema#string

P698

23645285

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer